Crolibulin
Tier C — Watch / tradeCrolibulin
Targets：Tubulin
Indications (approved)：Lymphoma, Anaplastic thyroid cancer, Solid tumour
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| CROLI-001 | 6948-30-7 | 3-bromo-4,5-dimethoxybenzaldehyde |
| CROLI-002 | 109-77-3Available | malononitrile |
| CROLI-003 | 59649-56-8 | 2,3-diaminophenol |
| CROLI-004 | 475576-83-1 | 2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile |
| Crolibulin | - | (R)-2,7,8-triamino-4-(3-bromo-4,5-dimethoxyphenyl)-4H-chromene-3-carbonitrile |
Frequently asked questions
What are the approved indications of Crolibulin?
Approved indications include: Lymphoma, Anaplastic thyroid cancer, Solid tumour.
When does the Crolibulin patent expire?
No public expiry year is available for Crolibulin yet; this page updates once verified.
How many synthesis routes are recorded for Crolibulin?
1 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Crolibulin intermediates?
1 intermediate CAS of Crolibulin are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Crolibulin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-19